Physician profile
Thomas Barman
NPI 1881704286
$407.55
in general payments reported to CMS, 2019-2025
11 companies · $37.06 in 2025
The $37.06 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.08 · 2021: $62.93 · 2022: $155 · 2023: $69.76 · 2024: $71.90 · 2025: $37.06.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $178.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $160.54 | 2021-2024 | Freestyle Libre 3 |
| Lilly USA, LLC | $45.42 | 2022-2023 | Mounjaro |
| Dexcom, INC. | $35.19 | 2019-2024 | Dexcom G6 Transmitter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.25 | 2021 | |
| Pfizer INC. | $28.02 | 2023-2025 | |
| Xeris Pharmaceuticals, INC. | $24.29 | 2024 | Gvoke Hypopen |
| Recor Medical INC | $22.23 | 2025 | Paradise Ultrasound Renal Denervation System |
| Novo Nordisk INC | $18.64 | 2022 | |
| Janssen Pharmaceuticals, INC | $17.73 | 2022 | |
| Sunovion Pharmaceuticals INC. | $13.48 | 2022 | |
| Boston Scientific Corporation | $12.76 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Barman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.